Skip to main content

Table 3 Variables independently associated with (A) plasma TF, (B) plasma suPAR, (C) endothelial dysfunctions markers, (D) Cu/Zn SOD, and neopterin levels in patients with CKD

From: Indoxyl sulfate – the uremic toxin linking hemostatic system disturbances with the prevalence of cardiovascular disease in patients with chronic kidney disease

 

Independent variable

Regression coefficient

P value

A

TF

TM

0.489

0.007

Multiple R for variables in the model– 0.490, multiple R2 – 0.239, adjusted R2 – 0.211, p < 0.007

B

suPAR

uPA

0.418

<0.0001

hs-CRP

0.373

0.0002

neopterin

0.500

0.0012

lymphocytes

−0.249

0.0046

TM

0.307

0.0084

sICAM-1

0.230

0.0171

vWF

0.157

0.0244

Cu/Zn SOD

0.156

0.0482

Multiple R for variables in the model – 0.985, multiple R2 – 0.971, adjusted R2 – 0.934, p < 0.0001

C

vWF

age

0.371

0.0104

F1 + 2

−0.276

0.0324

TM*

PAP

0.497

0.0003

IS

0.426

0.0008

suPAR

0.399

0.0024

sVCAM-1^

IS

0.562

0.0007

sICAM-1

0.557

0.0008

neopterin

0.359

0.0140

sICAM-1#

sVCAM-1

0.547

<0.0001

suPAR

0.357

0.0101

Multiple R for variables in the model – 0.633 (*0.863; ^0.960; #0.785), multiple R2 – 0.400 (*0.745; ^0.922; #0.617), adjusted R2 – 0.349 (*0.713; ^0.873; #0.574), all p < 0.0001

D

Cu/Zn SOD

IS

0.411

0.0031

TFPI

0.405

0.0071

sICAM-1

0.366

0.0093

F1 + 2

0.250

0.0442

neopterin*

sVCAM-1

0.659

0.0010

TM

0.598

0.0062

TF

0.496

0.0100

IS

0.456

0.0119

Hemoglobin

−0.324

0.0471

Multiple R for variables in the model – 0.655 (*0.926), multiple R2 – 0.429 (*0.857), adjusted R2 – 0.336 (*0.786), both p < 0.0001

  1. Abbreviations: TF tissue factor, TM thrombomodulin, suPAR soluble urokinase-type plasminogen activator receptor, uPA urinary plasminogen activator, hs-CRP high sensitivity C-reactive protein, sICAM-1 soluble intercellular adhesion molecule-1, vWF von Willebrand Factor, Cu/Zn SOD Cu/Zn superoxide dismutase 1, F1 + 2 prothrombin fragments 1 + 2, PAP plasmin-α2-antiplasmin, IS indoxyl sulfate, sVCAM-1 soluble vascular cell adhesion molecule-1, TFPI tissue factor pathway inhibitor; CKD – chronic kidney disease